Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an ...

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...

Previous studies have found that caffeine is the world's most popular stimulant and psychoactive sub­stance, and coffee is ...

Eli Lilly’s once-daily oral pill orforglipron outperformed oral semaglutide in reducing blood sugar and body weight over 52 ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...

China: A new treatment approach for diabetic macular edema (DME), combining an initial intravitreal anti-vascular endothelial ...

Four weeks of a 10-minute evening cosmetic routine with self-massage improved self-reported sleep quality, state anxiety, ...

The latest research indicates that consuming up to 400 mg of caffeine/day (equivalent to up to 5, 8-ounce cups of caffeinated ...

Cancer therapy has dramatically changed over the past many decades, not only in efficacy but also complexity, with targeted ...

AI makes the first 80% of development feel fast, but hides architectural complexity until it's too late. To prevent system ...

Introduction Physical exercise has been used to assist smoking cessation, but supervised programmes are bounded by limited ...

The latest research indicates that consuming up to 400 mg of caffeine/day (equivalent to up to 5, 8-ounce cups of caffeinated ...